BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 20306679)

  • 1. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.
    Zhu F; Ramadan G; Davies B; Margolis DA; Keever-Taylor CA
    Clin Exp Immunol; 2008 Feb; 151(2):284-96. PubMed ID: 18005260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro expansion of human γδ and CD56(+) T-cells by Aspergillus-antigen loaded fast dendritic cells in the presence of exogenous interleukin-12.
    Ramadan G
    Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):309-16. PubMed ID: 21854188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.
    Sun Q; Burton RL; Dai LJ; Britt WJ; Lucas KG
    J Immunol; 2000 Oct; 165(7):4105-11. PubMed ID: 11034422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Aspergillus-specific T lymphocytes with cytotoxic activity.
    Ramadan G
    Egypt J Immunol; 2004; 11(2):59-70. PubMed ID: 16734118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.
    Gallot G; Vollant S; Vivien R; Clémenceau B; Ferrand C; Tiberghien P; Gaschet J; Robillard N; Vié H
    Clin Exp Immunol; 2006 Apr; 144(1):158-68. PubMed ID: 16542378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.
    Ramadan G; Davies B; Kurup VP; Keever-Taylor CA
    Clin Exp Immunol; 2005 Apr; 140(1):81-91. PubMed ID: 15762878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
    Chen GH; Gu B; Chen F; Wang Y; Qiao M; Liu HW; Feng YF; Dai LJ; Zhu ZL; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1597-601. PubMed ID: 24370055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
    Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
    Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
    Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.
    Ho WY; Nguyen HN; Wolfl M; Kuball J; Greenberg PD
    J Immunol Methods; 2006 Mar; 310(1-2):40-52. PubMed ID: 16469329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
    Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S
    Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
    Boyle TJ; Berend KR; DiMaio JM; Coles RE; Via DF; Lyerly HK
    Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir.
    Keever-Taylor CA; Behn B; Konings S; Orentas R; Davies B; Margolis D
    Cytotherapy; 2003; 5(4):323-35. PubMed ID: 12944239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.